Neovacs S.A. (ALNEV) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.10x
Neovacs S.A. (ALNEV) has a Cash Flow Reinvestment Rate of 0.10x as of December 2023, reinvesting €150.45K (capex €150.45K ) from operating cash flow of €1.47 Million. See financial agility of Neovacs S.A. to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
0.10x
(Capex + Investments) / Operating CF
Total Reinvested
€150.45K
Capex + Investments
Operating Cash Flow
€1.47 Million
EUR
Capital Expenditures
€150.45K
EUR
Annual Cash Flow Reinvestment Rate for Neovacs S.A. (None–None)
Year-by-year capital reinvestment analysis for Neovacs S.A.. For the full cash flow conversion analysis, see ALNEV cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow